Systematic review of oral manifestations related to hyperparathyroidism

[1] Silva BC(2015)Parathyroid hormone: anabolic and catabolic actions on the skeleton Curr Opin Pharmacol 22 41-50

[2] Bilezikian JP(2011)Catabolic and anabolic actions of parathyroid hormone on the skeleton J Endocrinol Investig 34 801-810

[3] Silva BC(1945)Bone changes in the jaws caused by renal hyperparathyroidism J Periodontol 16 94-731

[4] Costa AG(1966)Secondary hyperparathyroidism as a cause of generalized enlargement of the maxilla and mandible. Report of a case Oral Surg Oral med Oral Pathol Oral Radiol Endod. 21 724-1878

[5] Cusano NE(2009)Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review J Clin Endocrinol Metab 94 1853-177

[6] Kousteni S(2006)3rd Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease J Bone Miner res 21 171-272

[7] Bilezikian JP(2013)Chronic kidney disease: global dimensions and perspectives Lancet 382 260-111

[8] Weinmann J(2010)Orbital involvement in craniofacial brown tumors Ophthal Plast Reconstr Surg 26 106-e96

[9] Nathan AS(2009)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement PLoS med 6 e1000097-642

[10] Traiger J(2011)Cushing syndrome secondary to a thymic carcinoid tumor due to multiple endocrine neoplasia type 1 Endocr Pract 17 e92-886

[1] Silva BC(2015)Parathyroid hormone: anabolic and catabolic actions on the skeleton Curr Opin Pharmacol 22 41-50

[2] Bilezikian JP(2011)Catabolic and anabolic actions of parathyroid hormone on the skeleton J Endocrinol Investig 34 801-810

[3] Silva BC(1945)Bone changes in the jaws caused by renal hyperparathyroidism J Periodontol 16 94-731

[4] Costa AG(1966)Secondary hyperparathyroidism as a cause of generalized enlargement of the maxilla and mandible. Report of a case Oral Surg Oral med Oral Pathol Oral Radiol Endod. 21 724-1878

[5] Cusano NE(2009)Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review J Clin Endocrinol Metab 94 1853-177

[6] Kousteni S(2006)3rd Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease J Bone Miner res 21 171-272

[7] Bilezikian JP(2013)Chronic kidney disease: global dimensions and perspectives Lancet 382 260-111

[8] Weinmann J(2010)Orbital involvement in craniofacial brown tumors Ophthal Plast Reconstr Surg 26 106-e96

[9] Nathan AS(2009)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement PLoS med 6 e1000097-642

[10] Traiger J(2011)Cushing syndrome secondary to a thymic carcinoid tumor due to multiple endocrine neoplasia type 1 Endocr Pract 17 e92-886